← Back to Clinical Trials
Recruiting NCT06907901

NCT06907901 Reliability of PHAS in Postural Hyperkyphosis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06907901
Status Recruiting
Phase
Sponsor Istanbul University - Cerrahpasa
Condition Postural Kyphosis
Study Type OBSERVATIONAL
Enrollment 128 participants
Start Date 2025-06-01
Primary Completion 2026-05-01

Eligibility & Interventions

Sex All sexes
Min Age 8 Years
Max Age 65 Years
Study Type OBSERVATIONAL
Interventions
PHAS Assessment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 128 participants in total. It began in 2025-06-01 with a primary completion date of 2026-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This observational, cross-sectional study aims to evaluate the reliability of the Postural Habits and Awareness Scale (PHAS) in patients with postural hyperkyphosis. The PHAS is designed to assess individuals' postural awareness and habits through four subscales. A total of 128 participants diagnosed with postural hyperkyphosis will complete the PHAS and the Kyphosis-Specific Spinal Appearance Questionnaire (KSSA). Test-retest reliability will be assessed by reapplying the PHAS after two weeks. Internal consistency, test-retest reliability, and concurrent validity will be analyzed. The study aims to provide a valid and reliable tool for evaluating postural awareness in clinical practice and future rehabilitation studies.

Eligibility Criteria

Inclusion Criteria: * Age between 8 and 65 years * Diagnosed with postural hyperkyphosis (Cobb angle ≥ 50° confirmed by clinical and radiological evaluation) * Ability to perform daily activities independently * Voluntary participation and signed informed consent Exclusion Criteria: * Presence of scoliosis or other spinal deformities * Kyphosis due to severe osteoporosis or pathological fractures * Diagnosis of ankylosing spondylitis or other inflammatory spinal diseases * Functional limitations due to acute or chronic pain * Previous postural awareness training or spinal rehabilitation within the last 6 months * Cognitive impairment or severe psychiatric disorder preventing independent questionnaire completion

Contact & Investigator

Central Contact

Kübra Kardeş, PhD

✉ kubra.koce@istinye.edu.tr

📞 905387115631

Principal Investigator

Ayşe Zengin Alpözgen, Assoc. Prof.

PRINCIPAL INVESTIGATOR

Istanbul University - Cerrahpasa

Frequently Asked Questions

Who can join the NCT06907901 clinical trial?

This trial is open to participants of all sexes, aged 8 Years or older, up to 65 Years, studying Postural Kyphosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06907901 currently recruiting?

Yes, NCT06907901 is actively recruiting participants. Contact the research team at kubra.koce@istinye.edu.tr for enrollment information.

Where is the NCT06907901 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06907901 clinical trial?

NCT06907901 is sponsored by Istanbul University - Cerrahpasa. The principal investigator is Ayşe Zengin Alpözgen, Assoc. Prof. at Istanbul University - Cerrahpasa. The trial plans to enroll 128 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology